AstraZeneca PLC (AZN)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 8, 2025 | $0.52 | 2025-08-08 | 2025-08-08 |
| March 24, 2025 | $1.05 | 2025-02-21 | 2025-02-21 |
| September 9, 2024 | $0.50 | 2024-08-09 | 2024-08-09 |
| March 25, 2024 | $0.98 | 2024-02-22 | 2024-02-23 |
| September 11, 2023 | $0.47 | 2023-08-10 | 2023-08-11 |
Dividends Summary
- AstraZeneca PLC has issued 45 dividend payments over the past 22 years
- The most recent dividend was paid 57 days ago, on September 8, 2025
- The highest dividend payed out to investors during this period was $1.95 per share
- The average dividend paid during this period was $0.88 per share.
Company News
IonQ, a quantum computing company, has seen a 47% stock surge this year. While promising, the technology is not yet commercially viable, with potential widespread use potentially 5-10 years away. The company faces significant challenges including high research costs, competition from tech giants, and uncertain commercial timeline.
Step Pharma has appointed Dr. Karen Smith as Chief Medical Officer, bringing over 25 years of pharmaceutical experience to advance their CTPS1 inhibitor dencatistat across multiple cancer and blood disorder indications.
Chinese biotech Eccogene is preparing for a Hong Kong IPO, leveraging a significant licensing deal with AstraZeneca for an experimental oral weight-loss drug that could challenge existing anti-obesity treatments.
President Trump announced a 100% tariff on branded and patented pharmaceutical products starting October 1, 2025, causing significant market disruption and raising concerns about global pharmaceutical supply chains and trade policy.
AstraZeneca reported strong Q2 results, beating estimates for earnings and sales. The company's key drugs like Tagrisso, Ultomiris, Farxiga, and Calquence performed well, while Lynparza and Imfinzi sales were slightly weak. AstraZeneca raised its sales and earnings growth expectations for the year, citing a strong first-half performance.